CA
AMN icon

Claris Advisors’s AMN Healthcare AMN Stock Holding History

Claris Advisors’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$127 – 128
2024
Q3 		$127 Buy
+3
New +$157 ﹤0.01% 1089

Other funds holding AMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Claris Advisors's AMN Position: Q4 2024 in Review

Claris Advisors sold out of AMN Healthcare (AMN) in Q4 2024, closing a stake of 3 shares — an estimated $127 sold.

Claris Advisors first reported a position in AMN in Q3 2024 and held it in 1 quarter. The position peaked at $127 in Q3 2024. 278 funds tracked by Wall St. Rank hold AMN as of Q4 2024.

  • Claris Advisors reported no remaining AMN Healthcare position as of Q4 2024 after selling out during the quarter.
  • Claris Advisors sold 3 AMN Healthcare shares in Q4 2024, an estimated $127.
  • Claris Advisors first reported a position in AMN Healthcare in Q3 2024 and held it in 1 quarter.
  • Claris Advisors's AMN Healthcare position peaked at $127 in Q3 2024.
  • 278 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.